Literature DB >> 15212121

Cerivastatin does not prevent oxidative injury of human aortic endothelial cells.

Sharif Al-Ruzzeh1, Ilona Schmidt, Koki Nakamura, Adrian Chester, Charles Ilsley, Mohamed Amrani.   

Abstract

The anti-atherogenic properties of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) have been well established in several circulatory beds. Increasing evidence suggests that statins may help attenuate ischemia-reperfusion injury, a beneficial effect that may be related to the antioxidant capabilities of statins; however, this remains controversial. We performed this study to determine whether the HMG-CoA reductase inhibitor cerivastatin can prevent oxidative stress-induced injury in cultured human aortic endothelial cells (HAEC). The HAEC were subjected to oxidative stress in the absence and presence of increasing concentrations of cerivastatin (50 nM-1,000 nM). Oxidative stress was induced by increasing concentrations of hydrogen peroxide or endogenous superoxide anions generated by the inhibition of superoxide dismutase using diethylthiocarbamate (10 mM). Cell viability and mitochondrial activity were measured by mitochondria-dependent 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) conversion. Cell morphology was also examined using light microscopy. Exposing HAEC to cerivastatin for 24 hours had no effect on cell viability using both cell morphology and MTT conversion: the HAEC incubated in 100 nM cerivastatin had 90% +/- 2.2% viability of the control. As expected, hydrogen peroxide produced a concentration-dependent decrease in cell viability. Varying concentrations of cerivastatin pretreatment for < or = 18 hours showed no protection of HAEC against hydrogen peroxide-induced injury. As a positive control, the prototype antioxidant N-acetyl-L-cysteine was cytoprotective even with the highest hydrogen peroxide concentration. Neither cerivastatin nor N-acetyl-L-cysteine protected HAEC against diethylthiocarbamate-induced oxidative injury at any concentration. In this study, cerivastatin did not protect cultured HAEC against oxidative stress induced by hydrogen peroxide or diethylthiocarbamate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212121      PMCID: PMC427370     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  22 in total

Review 1.  Oxidative stress, F2-isoprostanes and endothelial dysfunction in hypercholesterolemia.

Authors:  C Palombo; V Lubrano; T Sampietro
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

2.  Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.

Authors:  A H Wagner; T Köhler; U Rückschloss; I Just; M Hecker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-01       Impact factor: 8.311

3.  Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

Authors:  U Laufs; V La Fata; J Plutzky; J K Liao
Journal:  Circulation       Date:  1998-03-31       Impact factor: 29.690

4.  Effects of Simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia.

Authors:  A Nordøy; K H Bønaa; H Nilsen; R K Berge; J B Hansen; O C Ingebretsen
Journal:  J Intern Med       Date:  1998-02       Impact factor: 8.989

5.  Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment.

Authors:  M Yamada; Z Huang; T Dalkara; M Endres; U Laufs; C Waeber; P L Huang; J K Liao; M A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  2000-04       Impact factor: 6.200

6.  [Simvastatin and ischemia-reperfusion damage: its effects on apoptotic myocyte death and on the endothelial expression of nitric-oxide synthetase in an experimental model of the isolated rat heart].

Authors:  P Di Napoli; A Maggi; R Spina; L Barsotti; A A Taccardi; L Stuppia; G Vianale; G Palka; A Barsotti
Journal:  Cardiologia       Date:  1999-01

Review 7.  Preclinical and clinical pharmacology of cerivastatin.

Authors:  H Bischoff; A H Heller
Journal:  Am J Cardiol       Date:  1998-08-27       Impact factor: 2.778

Review 8.  Neuroprotective properties of statins in cerebral ischemia and stroke.

Authors:  C J Vaughan; N Delanty
Journal:  Stroke       Date:  1999-09       Impact factor: 7.914

9.  Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells.

Authors:  S W Ballinger; B Van Houten; G F Jin; C A Conklin; B F Godley
Journal:  Exp Eye Res       Date:  1999-06       Impact factor: 3.467

10.  Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

Authors:  M Endres; U Laufs; Z Huang; T Nakamura; P Huang; M A Moskowitz; J K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  2 in total

Review 1.  Lesions and lipids and radicals--O my!

Authors:  James M Wilson; Brian Walton
Journal:  Tex Heart Inst J       Date:  2004

2.  Protective Effects of Alternanthera sessilis Ethanolic Extract against TNF-α or H2O2-Induced Endothelial Activation in Human Aortic Endothelial Cells.

Authors:  Nur Nadia Mohd Razali; Soek Sin Teh; Siau Hui Mah; Yoke Keong Yong; Chin Theng Ng; Yang Mooi Lim; Lai Yen Fong
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-24       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.